Min Bao

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 2013 · 237 citations · Full text

Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma

H Cai, X Liu, Jian Zheng et al. · Oncogene · 2016 · 208 citations

Enhances Tumor-induced Angiogenesis, Angiogenesis, Glioma +9

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

Alan Kivitz, Ewa Olech, Michael Borofsky et al. · Arthritis Care & Research · 2014 · 143 citations · Full text

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · 2020 · 132 citations · Full text

Clinical Status, Clinical Infectious Disease, Clinical Trials +9

Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial

John H. Stone, Jian Han, Martin Aringer et al. · The Lancet Rheumatology · 2021 · 120 citations · Full text

Inflammation, Long-term Effect, Autoimmune Disease +6